Gastrointest Endosc1 Apr 2024
Researchers assessed EUS-RFA in 26 patients with unresectable pancreatic ductal adenocarcinoma, showing technical success in all cases and no major adverse events. Six months post-EUS-RFA, 42.3% of patients had improved overall survival and significant performance status enhancement. Tumor reduction and post-treatment necrotic areas were observed,…
Ann Surg Oncol1 Apr 2024
ICG-enhanced compression anatomical segment 7 segmentectomy in laparoscopic and robotic approach was successfully performed in two cases of Child-Pugh class A hepatocellular carcinoma. The technique enabled identification and resection of posterosuperior lesions with minimal liver stiffness and no postoperative complications, achieving R0-resection margins and quick…
Ann Surg Oncol1 Apr 2024
Researchers developed a 10-point score to predict post-recurrence survival (PRS) in patients with intrahepatic cholangiocarcinoma (iCC) following resection. This score successfully stratified patients based on their PRS likelihood, with lower scores associated with higher survival rates. The score included factors like tumor grade, resection margin,…
Ann Surg Oncol1 Apr 2024
Preoperative chemotherapy significantly increased overall survival in patients with liver-limited metastasis from gastric cancer who underwent hepatectomy, compared to upfront surgery. Patients who exhibited a partial response to preoperative chemotherapy had better outcomes than those with stable or progressive disease. The preoperative chemotherapy group also…
BMC Surg1 Apr 2024
Long-term outcomes of spleen-preserving distal pancreatectomy with splenic vessel resection showed higher prevalence of perigastric varices and lower platelet count compared to preservation. However, other complications such as gastric submucosal varices, splenic infarction, gastrointestinal bleeding, and hematologic parameters were similar between the two groups 5…
Ann Surg31 Mar 2024
Patients with Adenocarcinoma arising from Intraductal Papillary Mucinous Neoplasm (A-IPMN) have better long-term survival and lower recurrence rates compared to those with Pancreatic Ductal Adenocarcinoma (PDAC). PDAC patients showed inferior overall and disease-free survival, higher locoregional recurrence rates, but comparable systemic recurrence rates. A-IPMN patients…
World J Gastroenterol31 Mar 2024
After reviewing 45 articles on quality of life post-pancreatic surgery, it was found that recovery time varied between surgeries. Duodenum-preserving pancreatic head resection showed better quality of life compared to pancreaticoduodenectomy, with central pancreatectomy outcomes still debated. Recovery to preoperative levels took longer after total…
HPB & Spleen31 Mar 2024
Neoadjuvant chemotherapy for initially resectable colorectal cancer liver metastasis aims at tumor downsizing, evaluating biological behavior, and reducing postoperative recurrence risk. Balancing tumor reduction benefits with hepatic injury risks and the need for timely surgery is crucial. Precision medicine's role in tailoring neoadjuvant regimens, such…
Surg Endosc31 Mar 2024
When comparing long-term indwelling plastic stents (LTIS) to standard stent removal (SSR) after resolving pancreatic fluid collections (PFC) with endoscopic transmural drainage (ETD), LTIS showed significantly lower recurrence rates (3% vs. 23%). LTIS also decreased the need for further interventions. This meta-analysis of 16 studies…
JAMA30 Mar 2024
Researchers found that agile 3+ and agile 4 scores from vibration-controlled transient elastography had the highest discriminatory power in predicting liver-related events in patients with metabolic dysfunction-associated steatotic liver disease. These scores accurately categorized patients between high and low risk categories, with a decrease in…